News for LifeVantage Corporation (LFVN)

Phase 3 of the Evolve Compensation Plan launches on March 1, 2025, furthering opportunities for success SALT LAKE CITY, March 03, 2025 (GLOBE NEWSWIRE) -- L

**media[556084]**

Pennsylvania-based Lipella Pharmaceuticals Inc. (LIPO), a clinical-stage biotechnology company is up over 180 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Earnings Call Insights: LifeVantage Corporation (NASDAQ:LFVN) Q2 2025Management ViewCEO Steve Fife highlighted the success of the MindBody GLP-1 System,...

LifeVantage Corporation (NASDAQ:LFVN) Q2 2025 Earnings Conference Call February 5, 2025 4:30 PM ETCompany ParticipantsReed Anderson – Managing...

LifeVantage beats revenue and earnings expectations with FQ2 results.

**media[533429]**

**media[520485]**

TrueScience® Wins Silver for Most Innovative Product Line at Best in Biz Awards 2024 SALT LAKE CITY, Jan. 21, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporat

Technology leader brings decades of expertise in innovation, scalability and customer-focused solutions to accelerate LifeVantage's growth and digital transfor

B&G Foods (BGS) experienced a significant stock price drop of 5.01%, trading at $6.44 per share with a volume of 599,324 shares and a turnover rate of 0.76%. Th

LifeVantage (LFVN) expects 31% revenue growth in Q2 2025, raising fiscal 2025 guidance to $235-245 million.

As of Jan. 6, 2025, two stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their tradin...

Highlights the Destruction of 70% in Stockholder Value Under Garry Mauro’s 10-Year Reign as Chairman Notes the Radoff-Sudbury Group’s Aligned and Highly Qualified Director Candidates...